Petition Closed
Petitioning Corporate / Financial Media Relations Joan Campion, Pfizer and 27 others
8 responses

Sponsor Arbaclofen/STX 209 Study for children with Autism and Fragile X.


4,995
Supporters

Please read Holly Roo's Story about her son (Holly and Parker pictured above) and you will see how a trial drug, Arbaclofen, has changed her life and has impacted so many others living with autism and Fragile X. Arbaclofen has had amazing results for many participants yet Seaside Therapeutics has had to immediately terminate this trial without gaining FDA approval due to lack of funding. We hope that this story, and there are thousands more, can inspire pharmaceutical companies to see that it has been a lifesaver for so many families and can definitely be profitable!!

Letter to
Corporate / Financial Media Relations Joan Campion, Pfizer
UC Davis, Sacramento Randi Hagerman, MD
WLS Chicago ABC News
and 25 others
FRAXA Katie Clapp
National Institutes of Health Charlotte Armstrong
National Dessemination Center for Children with Disabilities
Emory University School of Medicine, The Department of Human Genetics Mika Nakamoto Kinoshita, M.D., Ph.D.
Rush University Dr. Elizabeth Berry-Kravis
U.S. House of Representatives
U.S. Senate
Illinois State House
Illinois State Senate
President of the United States
LaRoche Clinical Trials Genentech Clinical Trials
Office of Good Clinical Practice Food and Drug Administration FDA
Corporate, Financial and Global Public Health Mary Anne Rhyne, Glaxo Smith Kline
US Media Relations Julie Masow, Novartis
Associate Director, Public Affairs Chris Clark, Bristol Meyers Squibb
Head Media Relations, ROCHE Alexander Klauser
Sanofi, US Jack Cox, Head Media Relations
Director, Corporate Media Relations Johnson & Johnson, Carol Goodrich
Abbott Laboratories, External Communications Scott Davies
Corporate Media Relations (Tony Jewell): Tony Jewell, AstraZeneca
Sr. Director Global Corporate Communications Ed Sagebiel, Eli Lilly & Co
Corporate Communications Jeff LeRoy, Proctor & Gamble
PR, Corporate Communications All Pharmaceutical Companies -
MacDougall Biomedical Communications / Seaside Therapeutics PR Kari Watson
Illinois Governor
Sponsor Arbaclofen, STX 209 Clinical Trials and Studies for Chidren with Autism and Fragile X.